ComputChem Awarded $1,373,997in SBIR Phase II Funding from the National Institutes of Health
SBIR award will enable ComputChem to create software for better drug design and development November 19, 2021, Baltimore, MD – ComputChem, a technology company building next-generation platform solutions for in silico covalent drug design and lead optimization, today announced it has been awarded a $1,373,997 Small Business Innovation Research (SBIR) Phase II grant from the
